Cutaneous, oral and genital lichenoid reactions associated with retifanlimab, a new PD-1 inhibitor

J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e395-e396. doi: 10.1111/jdv.18785. Epub 2022 Dec 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal
  • Genitalia
  • Humans
  • Immune Checkpoint Inhibitors*
  • Lichenoid Eruptions* / chemically induced
  • Skin

Substances

  • Immune Checkpoint Inhibitors
  • Antibodies, Monoclonal